Table 1.
Backgrounds and organ involvements of the subjects.
| Total | IL-12B rs6871626 | LILRA3 rs103294 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| CC | AC | AA | p value | CC | CT | TT | p value | ||
| Number | 99 | 19 | 53 | 27 | 1 | 38 | 60 | ||
| Age at onset (years) | 31 ± 15 | 33 ± 16 | 30 ± 14 | 32 ± 15 | 0.91 | 45 | 35 ± 17 | 29 ± 13 | 0.052 |
| Female | 94 (95%) | 18 (95%) | 53 (100%) | 23 (85%) | 0.067 | 1 (100%) | 36 (95%) | 57 (95%) | 0.99 |
| Visual loss | 3 (3%) | 0 (0%) | 2 (4%) | 1 (4%) | 0.51 | 0 (0%) | 1 (3%) | 2 (3%) | 0.84 |
| Hypertension | 54 (56%) | 10 (53%) | 23 (45%) | 21 (78%) | 0.049* | 1 (100%) | 18 (50%) | 35 (58%) | 0.64 |
| Ischemic heart disease | 6 (6%) | 1 (5%) | 4 (8%) | 1 (4%) | 0.76 | 0 (0%) | 1 (3%) | 5 (8%) | 0.23 |
| Cerebrovascular event | 9 (9%) | 0 (0%) | 5 (10%) | 4 (15%) | 0.088 | 0 (0%) | 3 (8%) | 6 (10%) | 0.71 |
| Renal replacement therapy | 1 (1%) | 0 (0%) | 1 (2%) | 0 (0%) | 0.9 | 0 (0%) | 0 (0%0 | 1 (2%) | 0.33 |
| Inflammatory bowel disease | 7 (7%) | 1 (5%) | 2 (4%) | 4 (15%) | 0.16 | 0 (0%) | 2 (6%) | 5 (8%) | 0.56 |
| Ulcerative colitis | 5 (5%) | 1 (5%) | 1 (2%) | 3 (11%) | 0.28 | 0 (0%) | 2 (6%) | 3 (5%) | 0.97 |
| Crohn disease | 2 (2%) | 0 (0%) | 1 (2%) | 1 (4%) | 0.37 | 0 (0%) | 0 (0%) | 2 (3%) | 0.16 |
Data are n (%) or mean ± standard deviation.